PPT-Hyperbilirubinemia

Monica Stemmle Objectives Understand pathway where bilirubin comes from Physiologic vs Pathologic Hyperbilirubinemia Understand the risk for Kernicterus Understand why we care about hyperbilirubinemia. February 25 2017. Pediatrics . Christine Black-Langenau, DO. Osteopathic Residency Program Director, Byrn Mawr Hospital . Case 1. Newborn. 4-day-old 39 wks. 7lbs 2oz newborn. NSVD without complications. Breastfeeding every 2 hours. Discharged from nursery day 2. (TcB=8.6 at that time) Follow up in office at 4 days of life, appears jaundiced. . . Dr. Ravi Kant. Assistant Professor. Department of General Medicine. Introduction. Jaundice or . icterus. , is a yellowish discoloration of tissue resulting from the deposition of . bilirubin. .. Tissue deposition of bilirubin occurs only in the presence of serum . Pediatrics . Christine Black-Langenau, DO. Osteopathic Residency Program Director, Byrn Mawr Hospital . Case 1. Newborn. 4-day-old 39 wks. 7lbs 2oz newborn. NSVD without complications. Breastfeeding every 2 hours. Discharged from nursery day 2. (TcB=8.6 at that time) Follow up in office at 4 days of life, appears jaundiced. . Pediatric Continuity Clinic Curriculum. Onyekachukwu Osakwe. Objectives. Recognize the common findings in newborns with . hyperbilirubinemia. . . Describe bilirubin metabolism. Distinguish between direct and indirect . Presentation By: . Elizabeth Darling, RM, PhD;. Alexa Minichiello, MSc. 1. . CPG Development. Process. Overview. 2. . Example . Recommendations. 3. . Knowledge . Translation Resources. CPG Development PROCESS. Rawashdeh. , MD, . MSc. , FRCP, FRCPCH. Professor of Pediatrics . & . Gastroenterology. Jaundice: Definition. Yellow staining of the skin and sclera by abnormally high blood levels of the bile pigment . REV SP NFE DIG (A) er, we present two cases in which it is demonstrated that binemia exceeds 6 mg/dL. A complete workup, including Bosma P, Chowdhury JR, Jansen PH. Genetic inheritance of Gilbert’ DETECTION, MANAGEENT AN PREVENTION ATE NFANTS 6 NATIONAL HEALTH MISSION TANDARDREATMENTATE PRETERNFANTSMinistry of Health & Family Welfare Government of India NATIONAL HEALTH MISSION Ministry of Healt Guidelines Screening, Prevention and Management of Neonatal Hyperbilirubinemia January 20 20 N ational Neonatology Forum , India Screening, Prevention and Management of Neonatal Hyperbilirubinemia ). Lecturer Assistant. Kareem . AL-. Khafajy. Objectives:. At the end of the lecture the student will be able to: . Describe the concept of bilirubinemia. Recognize the causes of bilirubinemia. 3. . Brian A. Juber, MD. Neonatologist, Assistant Professor of Pediatrics. Children’s Hospital & Medical Center. University of Nebraska Medical Center. Omaha, NE. Objectives. The participant should be able to:. H. yperbilirubinemia in the Newborn . I. nfant 35 or More . W. eeks of Gestation. American Academy of Pediatrics. David G. Bundy MD, MPH is the Chief Quality Officer at MUSC Health Charleston and served as the Implementation Scientist on the clinical practice guideline development team. With the support of the guideline subcommittee, he developed this key driver diagram to support local and national quality improvement efforts. . . of. The Newborn. Khalid Altirkawi, M.D. Assistant Professor, Pediatrics. College of Medicine. King Saud University. Riyadh, Saudi Arabia . 2016. Disclaimer. . This presentation is meant to guide students when rotating in the NICU. . 2014. GOVT.AYURVED COLLEGE ,NANDED.. DEPARMENTAL STAFF. VD. V.U.GAWAI. . PROFESSOR &HOD. . VD. P.L.PATIL. . ASSO.PROFESSOR. . VD. A.T.PAWAR.